DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cocrystal Pharma, Inc. (Formerly B...
November 19 2018 - 11:40AM
Business Wire
The Schall Law Firm, a national shareholder rights litigation
firm, announces the filing of a class action lawsuit against
Cocrystal Pharma, Inc. (“Cocrystal” or “the Company”) (NASDAQ:
COCP) and of Cocrystal’s predecessor, BioZone Pharmaceuticals, Inc.
(BioZone) for violations of §§10(b) and 20(a) of the Securities
Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the
U.S. Securities and Exchange Commission.
Investors who purchased the Company's shares between September
23, 2013 and September 7, 2018, inclusive (the ''Class Period''),
are encouraged to contact the firm before November 19, 2018.
If you are a shareholder who suffered a loss, click here to
participate.
We also encourage you to contact Brian Schall, or Sherin
Mahdavian, of the Schall Law Firm, 1880 Century Park East, Suite
404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights
free of charge. You can also reach us through the firm's website
at www.schallfirm.com, or by email
at brian@schallfirm.com.
The class, in this case, has not yet been certified, and until
certification occurs, you are not represented by an attorney. If
you choose to take no action, you can remain an absent class
member.
According to the Complaint, the Company made false and
misleading statements to the market. The SEC filed a lawsuit on
September 7, 2018, against former officers of Cocrystal’s
predecessor company, BioZone, amongst other individuals and
corporations. The SEC alleges that the defendants were
participating in “highly profitable ‘pump-and-dump’ schemes . . .
from 2013 through 2018” involving three public companies, including
BioZone, that, “while enriching Defendants by millions of dollars,
left retail investors holding virtually worthless shares.” Based on
these facts, the Company’s public statements were false and
materially misleading throughout the class period. When the market
learned the truth, investors suffered losses.
Join the case to recover your losses.
The Schall Law Firm represents investors around the world and
specializes in securities class action lawsuits and shareholder
rights litigation.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and rules of
ethics.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20181119005590/en/
The Schall Law FirmBrian Schall, Esq.,Sherin Mahdavian,
Esq.,www.schallfirm.com310-301-3335info@schallfirm.com
Cocrystal Pharma (NASDAQ:COCP)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cocrystal Pharma (NASDAQ:COCP)
Historical Stock Chart
From Sep 2023 to Sep 2024